Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
mosedipimod (EC-18)
i
Other names:
EC-18
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Enzychem Lifesci
Drug class:
NK cell stimulant, Immunomodulator, TLR4 antagonist, Cytokine modulator, Polymorphonuclear neutrophil stimulant
Related drugs:
‹
pomalidomide (16)
CYNK-101 (8)
SNK01 (4)
IDP-023 (2)
CYNK-001 (2)
AFM13/AB-101 (1)
CTX-8573 (1)
EDIT-202 (1)
FT516 (1)
GDA-501 (1)
GTB-5550 (1)
IPH6501 (1)
KappaMab (1)
SAR443579 (1)
ASP7517 (0)
AgenT-797 (0)
cytotoxic lymphocyte-based cancer vaccine (0)
GCC4001 (0)
CAR-ITNK cells (0)
CAR-NK-CD19 cells (0)
CAR.70/IL15-transduced CB-NK cells (0)
CAR19-CYNK (0)
CB CAR-NK019 (0)
CBT101 (0)
CD123 targeted CAR-NK (0)
CD33/CLL1 dual CAR-NK cell (0)
CDH17 CAR-NK cell therapy (0)
CHM 2301 (0)
CIML NK (0)
CLDN6-CAR-NK cell therapy (0)
CNDO-109 (0)
CNK-UT (0)
CNTY-101 (0)
CT101a (0)
CYTO NK-102 (0)
DC vaccine for prostate cancer (0)
DF8100 (0)
DF9001 (0)
DM919 (0)
FATE-NK100 (0)
FT500 (0)
FT522 (0)
FT555 (0)
GAIA-102 (0)
GDA-201 (0)
GIC-102 (0)
GTA102 (0)
GTB-3650 (0)
GX-051 (0)
IBR733 (0)
primed NK cell therapy (0)
JD001 (0)
JD010 (0)
JD023 (0)
K-NK002 (0)
KN5501 (0)
MG4101 (0)
Magicell-NK (0)
NK/γδ T cell-enriched cell therapy (0)
NK92-CD16-158V (0)
NKG2D CAR-NK cell therapy (0)
NKG2D-CAR-NK92 cells (0)
CST-101 (0)
PB103 (0)
PNK-007 (0)
QN-019a (0)
QN-023a (0)
SAR445419 (0)
SAR445514 (0)
SENTI-202 (0)
SMT-NK (0)
SNC103 (0)
SZ003 (0)
SZ011 (0)
Super NK cell therapy (0)
TROP2-CAR-NK (0)
UD TGFbetai NK cells (0)
VAX-NK/HCC (0)
WU-NK-101 (0)
ZM008 (0)
cam1615SS1 (0)
dualCAR-NK19/70 (0)
m-ceNK cells (0)
inaleucel (0)
hydroxychloroquine (7)
quaratusugene ozeplasmid (3)
CMP-001 (3)
Orca-T (1)
SQZ-AAC-HPV (1)
SV-102 (1)
MAM-06.301 (1)
ABV-1501 (0)
ALT-801 (0)
ATA520 (0)
HLA-matched donor mononuclear enriched leukocytes (0)
BMS-986242 (0)
CEP-37250 (0)
CK0801 (0)
CO-1002 (0)
rimiducid activated rivogenlecleucel (0)
CyPep-1 (0)
GB221 (trastuzumab biosimilar) (0)
GSK2302024A (0)
Ganfule (0)
IL-17E (0)
IMCnyeso (0)
KFA115 (0)
MVA-BN-HER2 (0)
NOV-002 (0)
84AA-API 14AA (0)
nelipepimut-S (0)
ORB-011 (0)
engineered donor allograft cell therapy (0)
parvovirus H-1 (0)
FT1050+FT4145 programmed mPB (0)
allodepleted T-cell immunotherapeutics (0)
SER-401 (0)
SI-101 (0)
ScTIL (0)
ScTIL210 (0)
TAEK-VAC-HerBy vaccine (0)
TAK-012 (0)
TST010 (0)
Undisclosed CISH inactivated TIL (0)
alpha-tocopheroloxyacetic acid (0)
WTX212 (0)
SB-313 (0)
thymalfasin (0)
BAZE-X1 (0)
chlorogenic acid (0)
dendritic cell activation therapy (0)
DVX101 (0)
hV01 (0)
minocycline (0)
HF1K16 (0)
oral rhLF (0)
ex-vivo autologous dendritic cells vaccine (4)
TLR4 modulator program (0)
bezisterim (0)
E5564 (0)
SAR441000 (0)
pomalidomide (16)
CYNK-101 (8)
SNK01 (4)
IDP-023 (2)
CYNK-001 (2)
AFM13/AB-101 (1)
CTX-8573 (1)
EDIT-202 (1)
FT516 (1)
GDA-501 (1)
GTB-5550 (1)
IPH6501 (1)
KappaMab (1)
SAR443579 (1)
ASP7517 (0)
AgenT-797 (0)
cytotoxic lymphocyte-based cancer vaccine (0)
GCC4001 (0)
CAR-ITNK cells (0)
CAR-NK-CD19 cells (0)
CAR.70/IL15-transduced CB-NK cells (0)
CAR19-CYNK (0)
CB CAR-NK019 (0)
CBT101 (0)
CD123 targeted CAR-NK (0)
CD33/CLL1 dual CAR-NK cell (0)
CDH17 CAR-NK cell therapy (0)
CHM 2301 (0)
CIML NK (0)
CLDN6-CAR-NK cell therapy (0)
CNDO-109 (0)
CNK-UT (0)
CNTY-101 (0)
CT101a (0)
CYTO NK-102 (0)
DC vaccine for prostate cancer (0)
DF8100 (0)
DF9001 (0)
DM919 (0)
FATE-NK100 (0)
FT500 (0)
FT522 (0)
FT555 (0)
GAIA-102 (0)
GDA-201 (0)
GIC-102 (0)
GTA102 (0)
GTB-3650 (0)
GX-051 (0)
IBR733 (0)
primed NK cell therapy (0)
JD001 (0)
JD010 (0)
JD023 (0)
K-NK002 (0)
KN5501 (0)
MG4101 (0)
Magicell-NK (0)
NK/γδ T cell-enriched cell therapy (0)
NK92-CD16-158V (0)
NKG2D CAR-NK cell therapy (0)
NKG2D-CAR-NK92 cells (0)
CST-101 (0)
PB103 (0)
PNK-007 (0)
QN-019a (0)
QN-023a (0)
SAR445419 (0)
SAR445514 (0)
SENTI-202 (0)
SMT-NK (0)
SNC103 (0)
SZ003 (0)
SZ011 (0)
Super NK cell therapy (0)
TROP2-CAR-NK (0)
UD TGFbetai NK cells (0)
VAX-NK/HCC (0)
WU-NK-101 (0)
ZM008 (0)
cam1615SS1 (0)
dualCAR-NK19/70 (0)
m-ceNK cells (0)
inaleucel (0)
hydroxychloroquine (7)
quaratusugene ozeplasmid (3)
CMP-001 (3)
Orca-T (1)
SQZ-AAC-HPV (1)
SV-102 (1)
MAM-06.301 (1)
ABV-1501 (0)
ALT-801 (0)
ATA520 (0)
HLA-matched donor mononuclear enriched leukocytes (0)
BMS-986242 (0)
CEP-37250 (0)
CK0801 (0)
CO-1002 (0)
rimiducid activated rivogenlecleucel (0)
CyPep-1 (0)
GB221 (trastuzumab biosimilar) (0)
GSK2302024A (0)
Ganfule (0)
IL-17E (0)
IMCnyeso (0)
KFA115 (0)
MVA-BN-HER2 (0)
NOV-002 (0)
84AA-API 14AA (0)
nelipepimut-S (0)
ORB-011 (0)
engineered donor allograft cell therapy (0)
parvovirus H-1 (0)
FT1050+FT4145 programmed mPB (0)
allodepleted T-cell immunotherapeutics (0)
SER-401 (0)
SI-101 (0)
ScTIL (0)
ScTIL210 (0)
TAEK-VAC-HerBy vaccine (0)
TAK-012 (0)
TST010 (0)
Undisclosed CISH inactivated TIL (0)
alpha-tocopheroloxyacetic acid (0)
WTX212 (0)
SB-313 (0)
thymalfasin (0)
BAZE-X1 (0)
chlorogenic acid (0)
dendritic cell activation therapy (0)
DVX101 (0)
hV01 (0)
minocycline (0)
HF1K16 (0)
oral rhLF (0)
ex-vivo autologous dendritic cells vaccine (4)
TLR4 modulator program (0)
bezisterim (0)
E5564 (0)
SAR441000 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login